Industry Research Reports
Home > Reports > Food & Beverages > Global Acetylglucosamine Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Acetylglucosamine Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Food & Beverages
Published Date: 2025-11-16
Pages: 173 Pages
Report ld: 5459109
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Acetylglucosamine Market Size(US$)
CAGR 2025-2031
5.0%
Market Size,2031
USD 12.4
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 9.2 million
Market Forecast in 2031(Value)
US$ 12.4 million
CAGR
5.0%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Acetylglucosamine market is projected to grow from US$ 8.8 million in 2024 to US$ 12.4 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
At the regional level, China accounts for about 73 percent of the global market.
At present, the world"s major manufacturers include YSK, Zhejiang Fengrun Biology, Zhejiang Golden Shell Pharmaceutical, Zhejiang Aoxing Biology and Zhejiang Fengrun Biology, etc., the top three manufacturers account for about 49 percent of the market.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Acetylglucosamine market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- YSK
- Fengrun Biotech
- Golden-shell
- Aoxin-group
- Rixing Biotech
- Bio-gen Extracts
- AdvoCare
- Amicogen
- Merck KGaA
- Carl Roth
- Kaneka
- Ethical Naturals
- NOW Foods
- Beloor Bayir
- Vitaco Health
- Pure Encapsulations
- Kraeber & Co
- Source Naturals
- NutriCology
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Extraction of the Shell
- Microbial Fermentation
Segment by Application
- Cosmetics
- Health Care Products
- Drugs
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Acetylglucosamine study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Acetylglucosamine: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Acetylglucosamine Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Extraction of the Shell
1.2.3 Microbial Fermentation
1.3 Market Segmentation by Application
1.3.1 Global Acetylglucosamine Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cosmetics
1.3.3 Health Care Products
1.3.4 Drugs
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Acetylglucosamine Revenue Estimates and Forecasts 2020-2031
2.2 Global Acetylglucosamine Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Acetylglucosamine Sales Estimates and Forecasts 2020-2031
2.4 Global Acetylglucosamine Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Acetylglucosamine Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Acetylglucosamine Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Extraction of the Shell Market Size by Manufacturers
3.5.2 Microbial Fermentation Market Size by Manufacturers
3.6 Global Acetylglucosamine Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Acetylglucosamine Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Acetylglucosamine Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Acetylglucosamine Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Acetylglucosamine Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Acetylglucosamine Sales and Revenue by Type (2020-2031)
6.4 North America Acetylglucosamine Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Acetylglucosamine Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Acetylglucosamine Sales and Revenue by Type (2020-2031)
7.4 Europe Acetylglucosamine Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Acetylglucosamine Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Acetylglucosamine Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Acetylglucosamine Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Acetylglucosamine Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Acetylglucosamine Sales and Revenue by Type (2020-2031)
9.4 Central and South America Acetylglucosamine Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Acetylglucosamine Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Acetylglucosamine Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Acetylglucosamine Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Acetylglucosamine Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 YSK
11.1.1 YSK Corporation Information
11.1.2 YSK Business Overview
11.1.3 YSK Acetylglucosamine Product Models, Descriptions and Specifications
11.1.4 YSK Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 YSK Acetylglucosamine Sales by Product in 2024
11.1.6 YSK Acetylglucosamine Sales by Application in 2024
11.1.7 YSK Acetylglucosamine Sales by Geographic Area in 2024
11.1.8 YSK Acetylglucosamine SWOT Analysis
11.1.9 YSK Recent Developments
11.2 Fengrun Biotech
11.2.1 Fengrun Biotech Corporation Information
11.2.2 Fengrun Biotech Business Overview
11.2.3 Fengrun Biotech Acetylglucosamine Product Models, Descriptions and Specifications
11.2.4 Fengrun Biotech Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Fengrun Biotech Acetylglucosamine Sales by Product in 2024
11.2.6 Fengrun Biotech Acetylglucosamine Sales by Application in 2024
11.2.7 Fengrun Biotech Acetylglucosamine Sales by Geographic Area in 2024
11.2.8 Fengrun Biotech Acetylglucosamine SWOT Analysis
11.2.9 Fengrun Biotech Recent Developments
11.3 Golden-shell
11.3.1 Golden-shell Corporation Information
11.3.2 Golden-shell Business Overview
11.3.3 Golden-shell Acetylglucosamine Product Models, Descriptions and Specifications
11.3.4 Golden-shell Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Golden-shell Acetylglucosamine Sales by Product in 2024
11.3.6 Golden-shell Acetylglucosamine Sales by Application in 2024
11.3.7 Golden-shell Acetylglucosamine Sales by Geographic Area in 2024
11.3.8 Golden-shell Acetylglucosamine SWOT Analysis
11.3.9 Golden-shell Recent Developments
11.4 Aoxin-group
11.4.1 Aoxin-group Corporation Information
11.4.2 Aoxin-group Business Overview
11.4.3 Aoxin-group Acetylglucosamine Product Models, Descriptions and Specifications
11.4.4 Aoxin-group Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Aoxin-group Acetylglucosamine Sales by Product in 2024
11.4.6 Aoxin-group Acetylglucosamine Sales by Application in 2024
11.4.7 Aoxin-group Acetylglucosamine Sales by Geographic Area in 2024
11.4.8 Aoxin-group Acetylglucosamine SWOT Analysis
11.4.9 Aoxin-group Recent Developments
11.5 Rixing Biotech
11.5.1 Rixing Biotech Corporation Information
11.5.2 Rixing Biotech Business Overview
11.5.3 Rixing Biotech Acetylglucosamine Product Models, Descriptions and Specifications
11.5.4 Rixing Biotech Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Rixing Biotech Acetylglucosamine Sales by Product in 2024
11.5.6 Rixing Biotech Acetylglucosamine Sales by Application in 2024
11.5.7 Rixing Biotech Acetylglucosamine Sales by Geographic Area in 2024
11.5.8 Rixing Biotech Acetylglucosamine SWOT Analysis
11.5.9 Rixing Biotech Recent Developments
11.6 Bio-gen Extracts
11.6.1 Bio-gen Extracts Corporation Information
11.6.2 Bio-gen Extracts Business Overview
11.6.3 Bio-gen Extracts Acetylglucosamine Product Models, Descriptions and Specifications
11.6.4 Bio-gen Extracts Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Bio-gen Extracts Recent Developments
11.7 AdvoCare
11.7.1 AdvoCare Corporation Information
11.7.2 AdvoCare Business Overview
11.7.3 AdvoCare Acetylglucosamine Product Models, Descriptions and Specifications
11.7.4 AdvoCare Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 AdvoCare Recent Developments
11.8 Amicogen
11.8.1 Amicogen Corporation Information
11.8.2 Amicogen Business Overview
11.8.3 Amicogen Acetylglucosamine Product Models, Descriptions and Specifications
11.8.4 Amicogen Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Amicogen Recent Developments
11.9 Merck KGaA
11.9.1 Merck KGaA Corporation Information
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Acetylglucosamine Product Models, Descriptions and Specifications
11.9.4 Merck KGaA Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Merck KGaA Recent Developments
11.10 Carl Roth
11.10.1 Carl Roth Corporation Information
11.10.2 Carl Roth Business Overview
11.10.3 Carl Roth Acetylglucosamine Product Models, Descriptions and Specifications
11.10.4 Carl Roth Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Carl Roth Recent Developments
11.11 Kaneka
11.11.1 Kaneka Corporation Information
11.11.2 Kaneka Business Overview
11.11.3 Kaneka Acetylglucosamine Product Models, Descriptions and Specifications
11.11.4 Kaneka Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Kaneka Recent Developments
11.12 Ethical Naturals
11.12.1 Ethical Naturals Corporation Information
11.12.2 Ethical Naturals Business Overview
11.12.3 Ethical Naturals Acetylglucosamine Product Models, Descriptions and Specifications
11.12.4 Ethical Naturals Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Ethical Naturals Recent Developments
11.13 NOW Foods
11.13.1 NOW Foods Corporation Information
11.13.2 NOW Foods Business Overview
11.13.3 NOW Foods Acetylglucosamine Product Models, Descriptions and Specifications
11.13.4 NOW Foods Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 NOW Foods Recent Developments
11.14 Beloor Bayir
11.14.1 Beloor Bayir Corporation Information
11.14.2 Beloor Bayir Business Overview
11.14.3 Beloor Bayir Acetylglucosamine Product Models, Descriptions and Specifications
11.14.4 Beloor Bayir Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Beloor Bayir Recent Developments
11.15 Vitaco Health
11.15.1 Vitaco Health Corporation Information
11.15.2 Vitaco Health Business Overview
11.15.3 Vitaco Health Acetylglucosamine Product Models, Descriptions and Specifications
11.15.4 Vitaco Health Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Vitaco Health Recent Developments
11.16 Pure Encapsulations
11.16.1 Pure Encapsulations Corporation Information
11.16.2 Pure Encapsulations Business Overview
11.16.3 Pure Encapsulations Acetylglucosamine Product Models, Descriptions and Specifications
11.16.4 Pure Encapsulations Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Pure Encapsulations Recent Developments
11.17 Kraeber & Co
11.17.1 Kraeber & Co Corporation Information
11.17.2 Kraeber & Co Business Overview
11.17.3 Kraeber & Co Acetylglucosamine Product Models, Descriptions and Specifications
11.17.4 Kraeber & Co Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Kraeber & Co Recent Developments
11.18 Source Naturals
11.18.1 Source Naturals Corporation Information
11.18.2 Source Naturals Business Overview
11.18.3 Source Naturals Acetylglucosamine Product Models, Descriptions and Specifications
11.18.4 Source Naturals Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Source Naturals Recent Developments
11.19 NutriCology
11.19.1 NutriCology Corporation Information
11.19.2 NutriCology Business Overview
11.19.3 NutriCology Acetylglucosamine Product Models, Descriptions and Specifications
11.19.4 NutriCology Acetylglucosamine Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 NutriCology Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Acetylglucosamine Industry Chain
12.2 Acetylglucosamine Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Acetylglucosamine Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Acetylglucosamine Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Acetylglucosamine Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Acetylglucosamine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Acetylglucosamine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Acetylglucosamine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Acetylglucosamine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Acetylglucosamine Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Acetylglucosamine Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Acetylglucosamine Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Acetylglucosamine Sales by Region (2020-2025) & (Tons)
Table 8. Global Acetylglucosamine Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Acetylglucosamine Sales by Manufacturers (2020-2025) & (Tons)
Table 11. Global Acetylglucosamine Sales Share by Manufacturers (2020-2025)
Table 12. Global Acetylglucosamine Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Acetylglucosamine Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Acetylglucosamine by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acetylglucosamine as of 2024)
Table 16. Global Acetylglucosamine Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Acetylglucosamine Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 18. Key Manufacturers Acetylglucosamine Manufacturing Base and Headquarters
Table 19. Global Acetylglucosamine Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Acetylglucosamine Sales by Type (2020-2025) & (Tons)
Table 23. Global Acetylglucosamine Sales by Type (2026-2031) & (Tons)
Table 24. Global Acetylglucosamine Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Acetylglucosamine Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Acetylglucosamine ASP by Type (2020-2031) & (US$/Ton)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Acetylglucosamine Sales by Application (2020-2025) & (Tons)
Table 29. Global Acetylglucosamine Sales by Application (2026-2031) & (Tons)
Table 30. Acetylglucosamine High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Acetylglucosamine Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Acetylglucosamine Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Acetylglucosamine ASP by Application (2020-2031) & (US$/Ton)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Acetylglucosamine Growth Accelerators and Market Barriers
Table 37. North America Acetylglucosamine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Acetylglucosamine Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Acetylglucosamine Growth Accelerators and Market Barriers
Table 40. Europe Acetylglucosamine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Acetylglucosamine Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Acetylglucosamine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Acetylglucosamine Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Acetylglucosamine Growth Accelerators and Market Barriers
Table 45. Southeast Asia Acetylglucosamine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Acetylglucosamine Investment Opportunities and Key Challenges
Table 47. Central and South America Acetylglucosamine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Acetylglucosamine Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Acetylglucosamine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. YSK Corporation Information
Table 51. YSK Description and Major Businesses
Table 52. YSK Product Models, Descriptions and Specifications
Table 53. YSK Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 54. YSK Sales Value Proportion by Product in 2024
Table 55. YSK Sales Value Proportion by Application in 2024
Table 56. YSK Sales Value Proportion by Geographic Area in 2024
Table 57. YSK Acetylglucosamine SWOT Analysis
Table 58. YSK Recent Developments
Table 59. Fengrun Biotech Corporation Information
Table 60. Fengrun Biotech Description and Major Businesses
Table 61. Fengrun Biotech Product Models, Descriptions and Specifications
Table 62. Fengrun Biotech Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 63. Fengrun Biotech Sales Value Proportion by Product in 2024
Table 64. Fengrun Biotech Sales Value Proportion by Application in 2024
Table 65. Fengrun Biotech Sales Value Proportion by Geographic Area in 2024
Table 66. Fengrun Biotech Acetylglucosamine SWOT Analysis
Table 67. Fengrun Biotech Recent Developments
Table 68. Golden-shell Corporation Information
Table 69. Golden-shell Description and Major Businesses
Table 70. Golden-shell Product Models, Descriptions and Specifications
Table 71. Golden-shell Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 72. Golden-shell Sales Value Proportion by Product in 2024
Table 73. Golden-shell Sales Value Proportion by Application in 2024
Table 74. Golden-shell Sales Value Proportion by Geographic Area in 2024
Table 75. Golden-shell Acetylglucosamine SWOT Analysis
Table 76. Golden-shell Recent Developments
Table 77. Aoxin-group Corporation Information
Table 78. Aoxin-group Description and Major Businesses
Table 79. Aoxin-group Product Models, Descriptions and Specifications
Table 80. Aoxin-group Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 81. Aoxin-group Sales Value Proportion by Product in 2024
Table 82. Aoxin-group Sales Value Proportion by Application in 2024
Table 83. Aoxin-group Sales Value Proportion by Geographic Area in 2024
Table 84. Aoxin-group Acetylglucosamine SWOT Analysis
Table 85. Aoxin-group Recent Developments
Table 86. Rixing Biotech Corporation Information
Table 87. Rixing Biotech Description and Major Businesses
Table 88. Rixing Biotech Product Models, Descriptions and Specifications
Table 89. Rixing Biotech Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. Rixing Biotech Sales Value Proportion by Product in 2024
Table 91. Rixing Biotech Sales Value Proportion by Application in 2024
Table 92. Rixing Biotech Sales Value Proportion by Geographic Area in 2024
Table 93. Rixing Biotech Acetylglucosamine SWOT Analysis
Table 94. Rixing Biotech Recent Developments
Table 95. Bio-gen Extracts Corporation Information
Table 96. Bio-gen Extracts Description and Major Businesses
Table 97. Bio-gen Extracts Product Models, Descriptions and Specifications
Table 98. Bio-gen Extracts Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 99. Bio-gen Extracts Recent Developments
Table 100. AdvoCare Corporation Information
Table 101. AdvoCare Description and Major Businesses
Table 102. AdvoCare Product Models, Descriptions and Specifications
Table 103. AdvoCare Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 104. AdvoCare Recent Developments
Table 105. Amicogen Corporation Information
Table 106. Amicogen Description and Major Businesses
Table 107. Amicogen Product Models, Descriptions and Specifications
Table 108. Amicogen Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 109. Amicogen Recent Developments
Table 110. Merck KGaA Corporation Information
Table 111. Merck KGaA Description and Major Businesses
Table 112. Merck KGaA Product Models, Descriptions and Specifications
Table 113. Merck KGaA Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 114. Merck KGaA Recent Developments
Table 115. Carl Roth Corporation Information
Table 116. Carl Roth Description and Major Businesses
Table 117. Carl Roth Product Models, Descriptions and Specifications
Table 118. Carl Roth Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 119. Carl Roth Recent Developments
Table 120. Kaneka Corporation Information
Table 121. Kaneka Description and Major Businesses
Table 122. Kaneka Product Models, Descriptions and Specifications
Table 123. Kaneka Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 124. Kaneka Recent Developments
Table 125. Ethical Naturals Corporation Information
Table 126. Ethical Naturals Description and Major Businesses
Table 127. Ethical Naturals Product Models, Descriptions and Specifications
Table 128. Ethical Naturals Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 129. Ethical Naturals Recent Developments
Table 130. NOW Foods Corporation Information
Table 131. NOW Foods Description and Major Businesses
Table 132. NOW Foods Product Models, Descriptions and Specifications
Table 133. NOW Foods Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 134. NOW Foods Recent Developments
Table 135. Beloor Bayir Corporation Information
Table 136. Beloor Bayir Description and Major Businesses
Table 137. Beloor Bayir Product Models, Descriptions and Specifications
Table 138. Beloor Bayir Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 139. Beloor Bayir Recent Developments
Table 140. Vitaco Health Corporation Information
Table 141. Vitaco Health Description and Major Businesses
Table 142. Vitaco Health Product Models, Descriptions and Specifications
Table 143. Vitaco Health Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 144. Vitaco Health Recent Developments
Table 145. Pure Encapsulations Corporation Information
Table 146. Pure Encapsulations Description and Major Businesses
Table 147. Pure Encapsulations Product Models, Descriptions and Specifications
Table 148. Pure Encapsulations Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 149. Pure Encapsulations Recent Developments
Table 150. Kraeber & Co Corporation Information
Table 151. Kraeber & Co Description and Major Businesses
Table 152. Kraeber & Co Product Models, Descriptions and Specifications
Table 153. Kraeber & Co Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 154. Kraeber & Co Recent Developments
Table 155. Source Naturals Corporation Information
Table 156. Source Naturals Description and Major Businesses
Table 157. Source Naturals Product Models, Descriptions and Specifications
Table 158. Source Naturals Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 159. Source Naturals Recent Developments
Table 160. NutriCology Corporation Information
Table 161. NutriCology Description and Major Businesses
Table 162. NutriCology Product Models, Descriptions and Specifications
Table 163. NutriCology Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 164. NutriCology Recent Developments
Table 165. Key Raw Materials Distribution
Table 166. Raw Materials Key Suppliers
Table 167. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 168. Milestones in Production Technology Evolution
Table 169. Distributors List
Table 170. Market Trends and Market Evolution
Table 171. Market Drivers and Opportunities
Table 172. Market Challenges, Risks, and Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Acetylglucosamine Product Picture
Figure 2. Global Acetylglucosamine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Extraction of the Shell Product Picture
Figure 4. Microbial Fermentation Product Picture
Figure 5. Global Acetylglucosamine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Cosmetics
Figure 7. Health Care Products
Figure 8. Drugs
Figure 9. Others
Figure 10. Acetylglucosamine Report Years Considered
Figure 11. Global Acetylglucosamine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Acetylglucosamine Revenue (2020-2031) & (US$ Million)
Figure 13. Global Acetylglucosamine Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Acetylglucosamine Revenue Market Share by Region (2020-2031)
Figure 15. Global Acetylglucosamine Sales (2020-2031) & (Tons)
Figure 16. Global Acetylglucosamine Sales (CAGR) by Region (2020-2031) (Tons)
Figure 17. Global Acetylglucosamine Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Acetylglucosamine Sales Volume Market Share in 2024
Figure 19. Global Acetylglucosamine Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Extraction of the Shell Revenue Market Share by Manufacturer in 2024
Figure 22. Microbial Fermentation Revenue Market Share by Manufacturer in 2024
Figure 23. Global Acetylglucosamine Sales Market Share by Type (2020-2031)
Figure 24. Global Acetylglucosamine Revenue Market Share by Type (2020-2031)
Figure 25. Global Acetylglucosamine Sales Market Share by Application (2020-2031)
Figure 26. Global Acetylglucosamine Revenue Market Share by Application (2020-2031)
Figure 27. North America Acetylglucosamine Sales YoY (2020-2031) & (Tons)
Figure 28. North America Acetylglucosamine Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Acetylglucosamine Sales Revenue (US$ Million) in 2024
Figure 30. North America Acetylglucosamine Sales Volume (Tons) by Type (2020- 2031)
Figure 31. North America Acetylglucosamine Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Acetylglucosamine Sales Volume (Tons) by Application (2020-2031)
Figure 33. North America Acetylglucosamine Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Acetylglucosamine Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Acetylglucosamine Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Acetylglucosamine Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Acetylglucosamine Sales YoY (2020-2031) & (Tons)
Figure 38. Europe Acetylglucosamine Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Acetylglucosamine Sales Revenue (US$ Million) in 2024
Figure 40. Europe Acetylglucosamine Sales Volume (Tons) by Type (2020-2031)
Figure 41. Europe Acetylglucosamine Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Acetylglucosamine Sales Volume (Tons) by Application (2020-2031)
Figure 43. Europe Acetylglucosamine Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Acetylglucosamine Revenue (2020-2031) & (US$ Million)
Figure 45. France Acetylglucosamine Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Acetylglucosamine Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Acetylglucosamine Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Acetylglucosamine Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Acetylglucosamine Sales YoY (2020-2031) & (Tons)
Figure 50. Asia-Pacific Acetylglucosamine Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Acetylglucosamine Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Acetylglucosamine Sales Volume (Tons) by Type (2020- 2031)
Figure 53. Asia-Pacific Acetylglucosamine Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Acetylglucosamine Sales Volume (Tons) by Application (2020-2031)
Figure 55. Asia-Pacific Acetylglucosamine Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Acetylglucosamine Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Acetylglucosamine Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Acetylglucosamine Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Acetylglucosamine Revenue (2020-2031) & (US$ Million)
Figure 60. India Acetylglucosamine Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Acetylglucosamine Sales YoY (2020-2031) & (Tons)
Figure 62. Central and South America Acetylglucosamine Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Acetylglucosamine Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Acetylglucosamine Sales Volume (Tons) by Type (2021-2031)
Figure 65. Central and South America Acetylglucosamine Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Acetylglucosamine Sales Volume (Tons) by Application (2020-2031)
Figure 67. Central and South America Acetylglucosamine Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Acetylglucosamine Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Acetylglucosamine Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Acetylglucosamine Sales YoY (2020-2031) & (Tons)
Figure 71. Middle East and Africa Acetylglucosamine Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Acetylglucosamine Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Acetylglucosamine Sales Volume (Tons) by Type (2021-2031)
Figure 74. South America Acetylglucosamine Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Acetylglucosamine Sales Volume (Tons) by Application (2020-2031)
Figure 76. Middle East and Africa Acetylglucosamine Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Acetylglucosamine Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Acetylglucosamine Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Acetylglucosamine Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Acetylglucosamine Revenue (2020-2025) & (US$ Million)
Figure 81. Acetylglucosamine Industry Chain Mapping
Figure 82. Regional Acetylglucosamine Manufacturing Base Distribution (%)
Figure 83. Global Acetylglucosamine Production Market Share by Region (2020-2031)
Figure 84. Acetylglucosamine Production Process
Figure 85. Regional Acetylglucosamine Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Acetylglucosamine in 2031?
The global market size of Acetylglucosamine in 2031 was 12.4 Million USD.
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Acetylglucosamine market size from 2025 to 2031?
Which companies rank high in the global Acetylglucosamine market?
What was the global market size of Acetylglucosamine in 2025?
Related Reports
Acetylglucosamine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Acetylglucosamine was estimated to be worth US$ 9.24 million in 2025 and is projected to reach US$ 12.94 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 154
USD 3950.00
(Single User License)
Global Acetylglucosamine Market Research Report 2026
The global Acetylglucosamine market was valued at US$ 9.24 million in 2025 and is anticipated to reach US$ 12.94 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-04-19
Pages: 135
USD 2900.00
(Single User License)
Global Acetylglucosamine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Acetylglucosamine market size was US$ 8.8 million in 2024 and is forecast to a readjusted size of US$ 12.4 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-11-16
Pages: 104
USD 4250.00
(Single User License)
Acetylglucosamine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Acetylglucosamine was estimated to be worth US$ 8.8 million in 2024 and is forecast to a readjusted size of US$ 12.4 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 148
USD 3950.00
(Single User License)
Global Acetylglucosamine Market Research Report 2025
The global market for Acetylglucosamine was valued at US$ 8.8 million in the year 2024 and is projected to reach a revised size of US$ 12.4 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published Date: 2025-01-16
Pages: 105
USD 2900.00
(Single User License)
Global Acetylglucosamine Market Research Report 2024
The global Acetylglucosamine market was valued at US$ 8 million in 2023 and is anticipated to reach US$ 11 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
Published Date: 2024-02-07
Pages: 101
USD 2900.00
(Single User License)
Acetylglucosamine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Acetylglucosamine was estimated to be worth US$ 9.24 million in 2025 and is projected to reach US$ 12.94 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-06-16
Pages: 154
USD 3950.00 (Single User License)Global Acetylglucosamine Market Research Report 2026
The global Acetylglucosamine market was valued at US$ 9.24 million in 2025 and is anticipated to reach US$ 12.94 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-04-19
Pages: 135
USD 2900.00 (Single User License)Global Acetylglucosamine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Acetylglucosamine market size was US$ 8.8 million in 2024 and is forecast to a readjusted size of US$ 12.4 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 104
USD 4250.00 (Single User License)Acetylglucosamine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Acetylglucosamine was estimated to be worth US$ 8.8 million in 2024 and is forecast to a readjusted size of US$ 12.4 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 148
USD 3950.00 (Single User License)Global Acetylglucosamine Market Research Report 2025
The global market for Acetylglucosamine was valued at US$ 8.8 million in the year 2024 and is projected to reach a revised size of US$ 12.4 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published: 2025-01-16
Pages: 105
USD 2900.00 (Single User License)Global Acetylglucosamine Market Research Report 2024
The global Acetylglucosamine market was valued at US$ 8 million in 2023 and is anticipated to reach US$ 11 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
Published: 2024-02-07
Pages: 101
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now